Medartis Overview
- Year Founded
-
1997
- Status
-
Public
- Employees
-
949
- Stock Symbol
-
MED
- Investments
-
7
- Share Price
-
$104.48
- (As of Friday Closing)
Medartis General Information
Description
Medartis Holding AG is a medical device company. The company's product profile is divided into APTUS products, StealthFix Products, and MODUS products. APTUS includes products for the Hand, Wrist, Elbow, Shoulder, and Foot. MODUS comprises products for the mandible. Geographically, it derives the majority of its revenue from EMEA and also has a presence in APAC, LATAM, and USA.
Contact Information
Website
www.medartis.comCorporate Office
- Hochbergerstrasse 60E
- 4057 Basel
- Switzerland
Corporate Office
- Hochbergerstrasse 60E
- 4057 Basel
- Switzerland
Medartis Stock Performance
As of 18-Jul-2025, Medartis’s stock price is $104.48. Its current market cap is $1.3B with 12.4M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $104.48 | $103.61 | $49.98 - $106.11 | $1.3B | 12.4M | 4K | $0.33 |
Medartis Financials Summary
As of 31-Dec-2024, Medartis has a trailing 12-month revenue of $255M.
|
In Thousands, USD |
TTM 31-Dec-2024 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 |
|---|---|---|---|---|
| EV | 844,839 | 844,839 | 1,244,486 | 1,069,530 |
| Revenue | 255,342 | 255,342 | 235,845 | 191,473 |
| EBITDA | 32,774 | 32,774 | 27,862 | 11,993 |
| Net Income | 4,007 | 4,007 | 689 | (6,057) |
| Total Assets | 509,071 | 509,071 | 416,142 | 353,662 |
| Total Debt | 133,134 | 133,134 | 32,055 | 29,654 |
Medartis Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Medartis Comparisons
Industry
Financing
Details
Medartis Competitors (8)
One of Medartis’s 8 competitors is Integra Lifesciences, a Corporation company based in Princeton, NJ.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Integra Lifesciences | Corporation | Princeton, NJ | ||||
| Zimmer Biomet Holdings | Corporation | Warsaw, IN | ||||
| Orthofix International | Formerly PE-Backed | Lewisville, TX | ||||
| SeaSpine Holdings | Corporate Backed or Acquired | Carlsbad, CA | ||||
| Penumbra | Formerly VC-backed | Alameda, CA |
Medartis Patents
Medartis Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20250082378-A1 | Fibular nail outrigger surgical device | Pending | 13-Sep-2023 | ||
| US-20240293118-A1 | Compression fastener, instruments and methods | Pending | 02-Mar-2023 | ||
| US-20240216024-A1 | Orthopedic fasteners, instruments and methods | Pending | 30-Dec-2022 | ||
| DE-102023107666-A1 | Bone wedge implant | Pending | 31-Mar-2022 | ||
| AU-2023200422-A1 | Bone wedge implant and method | Pending | 31-Mar-2022 | A61B17/8095 |
Medartis Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Medartis Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Medartis Investments & Acquisitions (7)
Medartis’s most recent deal was a Merger/Acquisition with KeriMedical for . The deal was made on 17-Jul-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| KeriMedical | 17-Jul-2025 | Merger/Acquisition | Therapeutic Devices | ||
| Neoortho | 20-Mar-2025 | Merger/Acquisition | Surgical Devices | ||
| KeriMedical | 01-Jun-2023 | Secondary Transaction - Private | Therapeutic Devices | ||
| Nextremity Solutions | 05-Mar-2022 | Merger/Acquisition | Surgical Devices | ||
| KeriMedical | 30-Nov-2020 | Corporate | Therapeutic Devices |
Medartis ESG
Risk Overview
Risk Rating
Updated July, 01, 2025
27.32 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 14,697
Rank
Percentile
Healthcare
Industry
of 562
Rank
Percentile
Medical Devices
Subindustry
of 194
Rank
Percentile
Medartis Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Neoortho | Curitiba, Brazil | 2004 |
Medartis FAQs
-
When was Medartis founded?
Medartis was founded in 1997.
-
Where is Medartis headquartered?
Medartis is headquartered in Basel, Switzerland.
-
What is the size of Medartis?
Medartis has 949 total employees.
-
What industry is Medartis in?
Medartis’s primary industry is Therapeutic Devices.
-
Is Medartis a private or public company?
Medartis is a Public company.
-
What is Medartis’s stock symbol?
The ticker symbol for Medartis is MED.
-
What is the current stock price of Medartis?
As of 18-Jul-2025 the stock price of Medartis is $104.48.
-
What is the current market cap of Medartis?
The current market capitalization of Medartis is $1.3B.
-
What is Medartis’s current revenue?
The trailing twelve month revenue for Medartis is $255M.
-
Who are Medartis’s competitors?
Integra Lifesciences, Zimmer Biomet Holdings, Orthofix International, SeaSpine Holdings, and Penumbra are some of the 8 competitors of Medartis.
-
What is Medartis’s annual earnings per share (EPS)?
Medartis’s EPS for 12 months was $0.33.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
